Design and Rationale of the Assessment of the MindMics Recording System
1 other identifier
observational
29
1 country
1
Brief Summary
MindMics earbuds is a new technology designed enhance an individual's quality of life by continuously monitoring the heart rate, stress, and blood pressure allowing patients to make decisions regarding their health. MindMics has a working prototype of the ear buds which will perform all the conventional tasks of earbuds (listen to music, etc.), but, in addition, will measure heart rate, stress, blood pressure. The earbuds capture the sounds made by the various cardiac structures pulsing and moving blood. The sound is caused by the acceleration and deceleration of blood and the turbulence developed during rapid blood flow.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedFirst Submitted
Initial submission to the registry
October 18, 2021
CompletedFirst Posted
Study publicly available on registry
November 2, 2021
CompletedNovember 2, 2021
November 1, 2021
10 months
October 18, 2021
November 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Performance of the MindMics device for detecting Atrial Fibrillation based on inter-beat intervals
Sensitivity and specificity for detecting Atrial Fibrillation using inter-beat intervals and statistical measures based on inter-beat intervals
30 minutes
Study Arms (2)
Patients with AFib
Patients with AFib
Normal patients
Normal patients without AFib
Interventions
Eligibility Criteria
Approximately 25 patients will be recruited for group 1 from inpatient or outpatient office visits. Approximately 25 patients will be recruited for group 2 prior to direct-current cardioversion allowing collection of data from before and after cardioversion to document differences in recordings during sinus rhythm after having successful cardioversion from atrial fibrillation.
You may qualify if:
- AFib
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MindMics Inclead
Study Sites (1)
Prisma Health
Sumter, South Carolina, 29150, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2021
First Posted
November 2, 2021
Study Start
March 24, 2020
Primary Completion
January 31, 2021
Study Completion
January 31, 2021
Last Updated
November 2, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share